Vericel (VCEL) Common Equity (2010 - 2026)
Vericel (VCEL) reported Common Equity of $356.2 million for Q1 2026, up 20.56% on a YoY basis from $295.5 million in Q1 2025, and little changed sequentially from $354.6 million in Q4 2025.
Vericel (VCEL) Common Equity (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Common Equity data on file, last reported at $356.2 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 20.56% year-over-year to $356.2 million; the trailing twelve-month figure through Mar 2026 stood at $356.2 million (up 20.56% YoY), and the FY2025 full-year result was $354.6 million, up 21.47% from the prior year.
- Common Equity steadied at $356.2 million in Q1 2026, from $354.6 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $356.2 million in Q1 2026 to a low of $172.5 million in Q1 2022.
- A 5-year average of $247.2 million and a median of $233.9 million in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity advanced 12.46% in 2023 and advanced 29.22% in 2024, its largest moves.
- Tracing VCEL's Common Equity over 5 years: stood at $192.3 million in 2022, then rose by 17.52% to $226.0 million in 2023, then grew by 29.22% to $292.0 million in 2024, then climbed by 21.47% to $354.6 million in 2025, then grew by 0.45% to $356.2 million in 2026.
- Business Quant data shows VCEL's Common Equity at $356.2 million in Q1 2026, $354.6 million in Q4 2025, and $321.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 356.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356.23 Mn |
| Dec 31, 2025 | 354.64 Mn |
| Sep 30, 2025 | 321.86 Mn |
| Jun 30, 2025 | 306.81 Mn |
| Mar 31, 2025 | 295.49 Mn |
| Dec 31, 2024 | 291.97 Mn |
| Sep 30, 2024 | 257.47 Mn |
| Jun 30, 2024 | 242.98 Mn |
| Mar 31, 2024 | 233.90 Mn |
| Dec 31, 2023 | 225.95 Mn |
| Sep 30, 2023 | 204.38 Mn |
| Jun 30, 2023 | 198.93 Mn |
| Mar 31, 2023 | 193.98 Mn |
| Dec 31, 2022 | 192.27 Mn |
| Sep 30, 2022 | 177.84 Mn |
| Jun 30, 2022 | 174.82 Mn |
| Mar 31, 2022 | 172.49 Mn |
| Dec 31, 2021 | 170.46 Mn |
| Sep 30, 2021 | 156.78 Mn |
| Jun 30, 2021 | 151.09 Mn |